Condition: Allograft · Bioprosthesis · Tricuspid Valve Disease · Sponsor: Chelyabinsk Regional Clinical Hospital
The aim of the study is to evaluate early safety, clinical efficacy and long-term outcomes of mitral allografts and stented biological prosthesis in tricuspid valve replacement for primary tricuspid valve diseases.
This description comes directly from the study's public registry record.
Mikhail Nuzhdin, PhD · 0079068608612 · austesla2022@gmail.com
Yuri Malinovsky, PhD · 0073517493732 · mikhailnuzhdin@hotmail.com
Always discuss trial participation with your own doctor first.
| Department of Cardiac Surgery | Chelyabinsk, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06591000